Pharmacy

In 2018, Abbvie's rheumatoid arthritis drug Humira once again topped the list of best-selling drugs, according to a new analysis published in Nature.

The FDA approved a new generic of valsartan Feb. 12 to help relieve the shortage of the critical blood pressure drug that resulted from a string of recent recalls.

Facing pressure from investors, Rite Aid will replace three of its top executives and shed 400 corporate jobs.

The Senate Finance Committee has invited leaders from five major pharmacy benefit managers to testify at an April 3 hearing about high prescription drug costs in the U.S., according to CNBC.

The pharmacy manager of JNT Pharmacy in Brewster, N.Y., allegedly stole and resold more than $50,000 worth of diabetic test strips, according to the Times Herald-Record.

Pfizer will pay $975,000 to settle allegations that it misled customers with its copay coupon program, according to a STAT news report.

Citing headwinds in the U.S. generic drug market, Lupin Pharmaceuticals plans to lay off more than 60 employees from its research and development team, according to The Economic Times.

Roche's blockbuster breast cancer treatment Herceptin will face more competition after Pfizer's biosimilar won FDA approval March 11, according to Reuters.

Hospitals around the country have been jumping at the opportunity to offer patients CAR-T therapy, an often last-ditch effort to fight cancer. While the cutting-edge therapy has shown a lot of promise to save lives, it also leaves hospitals grappling…

An Oklahoma judge refused Purdue Pharma, Johnson & Johnson & Teva Pharmaceutical's request to delay a trial that accuses them of fueling the opioid crisis last week. Afterward, Purdue Pharma said its decision on whether to file for bankruptcy won't…